// App-Quantinova.ai

1353 : Targeting complement factor H mediated tumor immune and complement evasion as a next generation approach

Researchers

Presenter

  • Matthew Kraman

Principal Investigators

  • Carlo Zimarino

  • Danielle Minns

  • Jorge Dias

  • Chelsea Povall

  • Helen Graves

  • Bradley Holub

  • Ralph Minter

  • Jacob Galson

  • Jane Osbourn

  • Donna Finch

Medical Centers

  • Alchemab Therapeutics, Cambridge, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved